LEOCLAN Co.,Ltd. (TYO:7681)
Japan · Delayed Price · Currency is JPY 975.00
+15.00 (1.56%)
Jul 21, 2026, 3:30 PM JST
LEOCLAN Market Cap
LEOCLAN has a market cap or net worth of 5.68 billion as of July 20, 2026. Its market cap has decreased by -3.71% in one year.
Market Cap
5.68B
Enterprise Value
3.34B
Revenue
32.83B
Ranking
n/a
PE Ratio
132.13
Stock Price
975.00
ChartMarket Cap Chart
Since October 2, 2019, LEOCLAN's market cap has decreased from 6.65B to 5.68B, a decrease of -14.54%. That is a compound annual growth rate of -2.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 5.68B | -6.52% |
| Dec 30, 2025 | 6.08B | 9.37% |
| Dec 30, 2024 | 5.56B | 2.61% |
| Dec 29, 2023 | 5.42B | 0.58% |
| Dec 30, 2022 | 5.39B | -0.36% |
| Dec 30, 2021 | 5.41B | 22.82% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.06T |
| Takeda Pharmaceutical Company | 8.66T |
| HOYA Corporation | 8.43T |
| Otsuka Holdings | 5.78T |
| Nippon Chemiphar | 5.87B |
| Precision System Science | 5.71B |
| Shigematsu Works | 5.69B |
| Pharmarise Holdings | 5.68B |